Targeting CDK6 in hormone receptor-positive breast cancer: inhibitor discovery for precision oncology through dynamics study.

CDK6 is a critical protein involved in the regulation of the cell cycle, playing an important role in the progression from the G1 to S phase. In breast cancer, dysregulation of this protein is involved in tumour development and progression, particularly in hormone receptor-positive (HR+) breast cancers. The upregulation of CDK6 have been observed in a subset of breast cancers, leading to uncontrolled progression of the cell cycle and increased proliferation of cells.

A multitier virtual screening study of phytoconstituents as Myeloid Cell Leukemias 1 inhibitors.

Myeloid Cell Leukemia 1 (MCL1) is an anti-apoptotic protein that plays a critical role in regulating cell survival, particularly in cancer cells. It is a member of the BCL-2 family of proteins, which control the intrinsic pathway of apoptosis. MCL1 has emerged as a promising target for cancer therapy because it is overexpressed in a wide range of cancers, including breast, lung, prostate, and hematologic malignancies.

Doped SnO Nanomaterials for E-Nose Based Electrochemical Sensing of Biomarkers of Lung Cancer.

Lung cancer detection includes detection of a pattern formed by multiple volatile organic compounds. An individual material has limited selectivity and hence requires tailoring to improve the selectivity and sensing properties. An electronic nose (e-nose) is a concept/device that can help in achieving selectivity and specificity for multiple volatile organic compounds at the same time by using an array of sensors.